These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 1377326)
21. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties. Patacchini R; Quartara L; Rovero P; Goso C; Maggi CA J Pharmacol Exp Ther; 1993 Jan; 264(1):17-21. PubMed ID: 8380857 [TBL] [Abstract][Full Text] [Related]
22. Demonstration of two distinct tachykinin receptors in rat brain cortex. Cascieri MA; Chicchi GG; Liang T J Biol Chem; 1985 Feb; 260(3):1501-7. PubMed ID: 2578461 [TBL] [Abstract][Full Text] [Related]
23. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1. Nakamura M; Ofuji K; Chikama T; Nishida T Br J Pharmacol; 1997 Feb; 120(4):547-52. PubMed ID: 9051288 [TBL] [Abstract][Full Text] [Related]
24. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist. Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347 [TBL] [Abstract][Full Text] [Related]
25. Residue 78 in the second transmembrane domain of the neurokinin-1 receptor is important in coupling high affinity agonist binding to multiple second messenger responses. Brodbeck RM; Sachais BS; Krause JE Mol Pharmacol; 1995 May; 47(5):1065-71. PubMed ID: 7538194 [TBL] [Abstract][Full Text] [Related]
26. Eledoisin and Kassinin, but not Enterokassinin, stimulate ion transport in frog skin. Lippe C; Bellantuono V; Ardizzone C; Cassano G Peptides; 2004 Nov; 25(11):1971-5. PubMed ID: 15501529 [TBL] [Abstract][Full Text] [Related]
27. Stable expression of high affinity NK1 (substance P) and NK2 (neurokinin A) receptors but low affinity NK3 (neurokinin B) receptors in transfected CHO cells. Gether U; Marray T; Schwartz TW; Johansen TE FEBS Lett; 1992 Jan; 296(3):241-4. PubMed ID: 1311270 [TBL] [Abstract][Full Text] [Related]
28. The unpredicted high affinities of a large number of naturally occurring tachykinins for chimeric NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity. Tian Y; Wu LH; Oxender DL; Chung FZ J Biol Chem; 1996 Aug; 271(34):20250-7. PubMed ID: 8702757 [TBL] [Abstract][Full Text] [Related]
29. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor. Lew R; Geraghty DP; Drapeau G; Regoli D; Burcher E Eur J Pharmacol; 1990 Aug; 184(1):97-108. PubMed ID: 1698645 [TBL] [Abstract][Full Text] [Related]
30. The presence of NK3 tachykinin receptors on rat uterus. Barr AJ; Watson SP; Bernal AL; Nimmo AJ Eur J Pharmacol; 1991 Oct; 203(2):287-90. PubMed ID: 1724757 [TBL] [Abstract][Full Text] [Related]
31. Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut. Wang Y; Badgery-Parker T; Lovas S; Chartrel N; Vaudry H; Burcher E; Conlon JM Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):827-32. PubMed ID: 1332683 [TBL] [Abstract][Full Text] [Related]
32. Evidence of NK1 and NK2 tachykinin receptors and their involvement in histamine release in a murine mast cell line. Krumins SA; Broomfield CA Neuropeptides; 1992 Feb; 21(2):65-72. PubMed ID: 1372967 [TBL] [Abstract][Full Text] [Related]
33. Interaction of substance P and its N- and C-terminal fragments with Ca2+: implications for hormone action. Ananthanarayanan VS; Orlicky S Biopolymers; 1992 Dec; 32(12):1765-73. PubMed ID: 1282041 [TBL] [Abstract][Full Text] [Related]
34. Interaction of tachykinins with an adrenergic receptor in the rat urinary bladder. Mathison R; Solomos D Eur J Pharmacol; 1985 Mar; 109(3):327-33. PubMed ID: 2580719 [TBL] [Abstract][Full Text] [Related]
35. Tachykinins: effects on gastric secretion and emptying in rats. Improta G; Broccardo M Pharmacol Res; 1990; 22(5):605-10. PubMed ID: 2177557 [TBL] [Abstract][Full Text] [Related]
36. Agonists selective for tachykinin NK1 and NK3 receptors excite subpopulations of neurons in the rat medial habenula nucleus in vitro. Norris SK; Boden PR; Woodruff GN Eur J Pharmacol; 1993 Apr; 234(2-3):223-8. PubMed ID: 7683268 [TBL] [Abstract][Full Text] [Related]
37. Analysis of C-terminally substituted tachykinin-like peptide agonists by means of aequorin-based luminescent assays for human and insect neurokinin receptors. Torfs H; Detheux M; Oonk HB; Akerman KE; Poels J; Van Loy T; De Loof A; Vassart G; Parmentier M; Vanden Broeck J Biochem Pharmacol; 2002 May; 63(9):1675-82. PubMed ID: 12007570 [TBL] [Abstract][Full Text] [Related]
38. NK-1 receptor mediation of neurogenic plasma extravasation in rat skin. Andrews PV; Helme RD; Thomas KL Br J Pharmacol; 1989 Aug; 97(4):1232-8. PubMed ID: 2477105 [TBL] [Abstract][Full Text] [Related]
39. Involvement of NK1 receptors and importance of the N-terminal sequence of substance P in the stimulation of protein secretion in rat parotid glands. Rollandy I; Guillemain I; Imhoff V; Drapeau G; Regoli D; Rossignol B Eur J Pharmacol; 1991 Dec; 209(1-2):95-100. PubMed ID: 1726089 [TBL] [Abstract][Full Text] [Related]
40. Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors. Aramori I; Morikawa N; Zenkoh J; O'Donnell N; Iwami M; Kojo H; Notsu Y; Okuhara M; Ono S; Nakanishi S Eur J Pharmacol; 1994 Oct; 269(2):277-81. PubMed ID: 7531648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]